Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
August 17, 2025Open Access

Magnitude of Tuberculosis, its associated risk factors, Rifampicin resistance, and multi- drug resistance rate among TB presumptive patients at five selected Public Hospitals, Somali Region, Eastern Ethiopia, 2025. Retrospective cross-sectional study

View Full Paper
Ask AI
Bookmark
Share

Authors

BTBawlah TahirAOAbdi D. OsmanKFKalid Fuad

Discussion

Loading...

Member takes

Overview

Retrospective study finds 20.2% prevalence of tuberculosis and 10.8% rifampicin resistance in patients, highlighting major public health concerns.

Key Points

  • The overall magnitude of TB among patients was 20.2%, notably higher in males and younger patients, and despite treatment, drug resistance remains a concern.
  • Among confirmed TB cases, 10.8% were resistant to first-line anti-TB drugs, with rifampicin resistance also at 10.8%, indicating significant treatment challenges.
  • This analysis used a retrospective cross-sectional design with 460 patient records reviewed, employing systematic sampling to ensure representativeness of the data.
  • Higher TB incidence correlates with male gender and prior TB contact, underscoring specific risk factors that could aid targeted health interventions.

Cite This Study

Tahir et al. (2025) studied this question.

synapsesocial.com/papers/68af76bf7567bf4f94fefd74https://doi.org/10.21203/rs.3.rs-6997913/v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rifampicin resistance and associated factors of Mycobacterium tuberculosis among pulmonary tuberculosis-suspected patients in the Amhara National Regional State Comprehensive Specialized Hospitals, Ethiopia2026
  2. 2Prevalence of pulmonary tuberculosis and its associated risk factors among suspected patients visiting Durbete Primary Hospital, northwest Ethiopia: A cross-sectional study2025
  3. 3Prevalence of rifampicin resistance in pulmonary tuberculosis: A laboratory-based study2025
  4. 4Trends and Prevalence of Rifampicin-Resistant Tuberculosis at Ndola Teaching Hospital, Zambia (2020–2022)2025
  5. 5Community-level risk factors for active Pulmonary Tuberculosis and their implications for TB Control: An unmatched case-control study in Guji Zone, Oromia Region, Ethiopia2025